Literature DB >> 26996141

CrossTalk proposal: Intramyocellular ceramide accumulation does modulate insulin resistance.

Scott A Summers1, Bret H Goodpaster2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26996141      PMCID: PMC4800028          DOI: 10.1113/JP271676

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  32 in total

1.  Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis.

Authors:  Benjamin T Bikman; Yuguang Guan; Guanghou Shui; M Mobin Siddique; William L Holland; Ji Yun Kim; Gemma Fabriàs; Markus R Wenk; Scott A Summers
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

2.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

Authors:  Sarah M Turpin; Hayley T Nicholls; Diana M Willmes; Arnaud Mourier; Susanne Brodesser; Claudia M Wunderlich; Jan Mauer; Elaine Xu; Philipp Hammerschmidt; Hella S Brönneke; Aleksandra Trifunovic; Giuseppe LoSasso; F Thomas Wunderlich; Jan-Wilhelm Kornfeld; Matthias Blüher; Martin Krönke; Jens C Brüning
Journal:  Cell Metab       Date:  2014-10-07       Impact factor: 27.287

3.  Skeletal muscle ceramide species in men with abdominal obesity.

Authors:  M P de la Maza; J M Rodriguez; S Hirsch; L Leiva; G Barrera; D Bunout
Journal:  J Nutr Health Aging       Date:  2015-04       Impact factor: 4.075

4.  Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited.

Authors:  John J Dubé; Francesca Amati; Maja Stefanovic-Racic; Frederico G S Toledo; Sarah E Sauers; Bret H Goodpaster
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-04       Impact factor: 4.310

5.  An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.

Authors:  William L Holland; Andrew C Adams; Joseph T Brozinick; Hai H Bui; Yukiko Miyauchi; Christine M Kusminski; Steven M Bauer; Mark Wade; Esha Singhal; Christine C Cheng; Katherine Volk; Ming-Shang Kuo; Ruth Gordillo; Alexei Kharitonenkov; Philipp E Scherer
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

6.  Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans.

Authors:  Julia Szendroedi; Toru Yoshimura; Esther Phielix; Chrysi Koliaki; Mellissa Marcucci; Dongyan Zhang; Tomas Jelenik; Janette Müller; Christian Herder; Peter Nowotny; Gerald I Shulman; Michael Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

7.  Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.

Authors:  John R Ussher; Timothy R Koves; Virgilio J J Cadete; Liyan Zhang; Jagdip S Jaswal; Suzanne J Swyrd; David G Lopaschuk; Spencer D Proctor; Wendy Keung; Deborah M Muoio; Gary D Lopaschuk
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

8.  Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.

Authors:  James Boon; Andrew J Hoy; Romana Stark; Russell D Brown; Ruth C Meex; Darren C Henstridge; Simon Schenk; Peter J Meikle; Jeffrey F Horowitz; Bronwyn A Kingwell; Clinton R Bruce; Matthew J Watt
Journal:  Diabetes       Date:  2012-11-08       Impact factor: 9.461

9.  Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet.

Authors:  J T Brozinick; E Hawkins; H Hoang Bui; M-S Kuo; B Tan; P Kievit; K Grove
Journal:  Int J Obes (Lond)       Date:  2012-12-04       Impact factor: 5.095

10.  Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans.

Authors:  Bettina Nowotny; Lejla Zahiragic; Dorothea Krog; Peter J Nowotny; Christian Herder; Maren Carstensen; Toru Yoshimura; Julia Szendroedi; Esther Phielix; Peter Schadewaldt; Nanette C Schloot; Gerald I Shulman; Michael Roden
Journal:  Diabetes       Date:  2013-03-01       Impact factor: 9.461

View more
  22 in total

1.  Quantification of muscle triglyceride synthesis rate requires an adjustment for total triglyceride content.

Authors:  Rabia Asghar; Maria Chondronikola; Edgar L Dillon; William J Durham; Craig Porter; Zhanpin Wu; Maria Camacho-Hughes; Clark R Andersen; Heidi Spratt; Elena Volpi; Melinda Sheffield-Moore; Labros Sidossis; Robert R Wolfe; Nicola Abate; Demidmaa R Tuvdendorj
Journal:  J Lipid Res       Date:  2018-08-21       Impact factor: 5.922

2.  Skeletal muscle ceramides and relationship with insulin sensitivity after 2 weeks of simulated sedentary behaviour and recovery in healthy older adults.

Authors:  Paul T Reidy; Alec I McKenzie; Ziad Mahmassani; Vincent R Morrow; Nikol M Yonemura; Paul N Hopkins; Robin L Marcus; Matthew T Rondina; Yu Kuei Lin; Micah J Drummond
Journal:  J Physiol       Date:  2018-10-09       Impact factor: 5.182

Review 3.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

4.  Rebuttal from Max C. Petersen and Michael J. Jurczak.

Authors:  Max C Petersen; Michael J Jurczak
Journal:  J Physiol       Date:  2016-03-20       Impact factor: 5.182

5.  Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.

Authors:  Cen Xie; Tomoki Yagai; Yuhong Luo; Xianyi Liang; Tao Chen; Qiong Wang; Dongxue Sun; Jie Zhao; Sadeesh K Ramakrishnan; Lulu Sun; Chunmei Jiang; Xiang Xue; Yuan Tian; Kristopher W Krausz; Andrew D Patterson; Yatrik M Shah; Yue Wu; Changtao Jiang; Frank J Gonzalez
Journal:  Nat Med       Date:  2017-10-09       Impact factor: 53.440

6.  A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.

Authors:  Min Park; Vincent Kaddai; Jianhong Ching; Kevin T Fridianto; Ryan J Sieli; Shigeki Sugii; Scott A Summers
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

7.  Pharmacological inhibition of TLR4 ameliorates muscle and liver ceramide content after disuse in previously physically active mice.

Authors:  Alec I McKenzie; Paul T Reidy; Daniel S Nelson; Jade L Mulvey; Nikol M Yonemura; Jonathan J Petrocelli; Ziad S Mahmassani; Trevor S Tippetts; Scott A Summers; Katsuhiko Funai; Micah J Drummond
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-01-29       Impact factor: 3.619

Review 8.  Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.

Authors:  Peter J Meikle; Scott A Summers
Journal:  Nat Rev Endocrinol       Date:  2016-10-21       Impact factor: 43.330

Review 9.  The role of hypoxia-inducible factors in metabolic diseases.

Authors:  Frank J Gonzalez; Cen Xie; Changtao Jiang
Journal:  Nat Rev Endocrinol       Date:  2018-12       Impact factor: 43.330

Review 10.  Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Trends Pharmacol Sci       Date:  2017-05-24       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.